HALTING AGE-ASSOCIATED BRAIN PATHOLOGIES
BrainEver is a biopharmaceutical company developing a pipeline of novel therapies for patients suffering from neurodegenerative diseases
Neurodegenerative diseases due to an aging population are one of the largest challenges of our time
Our approach is to develop breakthrough therapies to halt neurodegenerative disease progression by stopping neuronal death and durably modifying the physiology and the metabolism of surviving neurons.
THE HP CONCEPT
Discovery that Homeoproteins are specific neuron maintenance and rejuvenation factors opens a novel approach to stopping neuro-degenerative disease progression.
BrainEver is developing a portfolio of drug candidates focused on major neurodegenerative diseases with significant unmet medical needs: ALS, Parkinson, and retina diseases.
Brainever announces the award of €2.5M funding from the European Innovation Council for its project on the use of Homeoproteins as novel therapies for neurodegenerative diseases.